LAKE STREET ADVISORS GROUP, LLC - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 63 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
LAKE STREET ADVISORS GROUP, LLC ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$207
-99.9%
35,3980.0%0.01%
-17.6%
Q3 2022$237,000
+59.1%
35,3980.0%0.02%
+54.5%
Q2 2022$149,000
+25.2%
35,3980.0%0.01%
+37.5%
Q1 2022$119,000
+6.2%
35,3980.0%0.01%
+14.3%
Q4 2021$112,000
-3.4%
35,3980.0%0.01%
-41.7%
Q3 2021$116,00035,3980.01%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,200,000$37,532,0007.45%
BVF INC/IL 2,336,609$39,863,0006.78%
ISZO CAPITAL MANAGEMENT LP 152,988$2,610,0004.54%
SENZAR ASSET MANAGEMENT, LLC 416,845$7,111,0001.80%
INGALLS & SNYDER LLC 1,056,000$18,015,0000.96%
Lyon Street Capital, LLC 86,011$1,467,0000.59%
DRIEHAUS CAPITAL MANAGEMENT LLC 430,982$7,353,0000.25%
AWM Investment Company, Inc. 137,212$2,340,0000.22%
ACUTA CAPITAL PARTNERS, LLC 49,051$837,0000.20%
Schonfeld Strategic Advisors LLC 61,831$1,055,0000.11%
View complete list of CONCERT PHARMACEUTICALS INC shareholders